Fundz

Biomica Raises $20 Million In A Financing Round To Advance Its Pipeline Of Microbiome-Based Therapeutics

PRIVATEDec 21, 2022

Amount Raised

$20 Million

Round Type

Funding Round

IsraelBiotechnologyTherapeuticsBiopharma

Investors

Shanghai Healthcare Capital

Description

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced the signing of a definitive agreement for a $20 million financing round, to be led by Shanghai Healthcare Capital (SHC). The financing is subject to customary closing conditions, including clearance by Chinese regulatory authorities.

Quick answer

Biomica raised $20 Million in a Funding Round round, dated December 21, 2022. Investors: Shanghai Healthcare Capital. Biomica is based in Israel.

How much did Biomica raise?
Biomica raised $20 Million in a Funding Round round on December 21, 2022.
Who invested in Biomica?
Shanghai Healthcare Capital is named as investors in this round.
What does Biomica do?
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform.
Where is Biomica based and how big is it?
Biomica is based in Israel.
Who are the decision-makers at Biomica?
Fundz holds 1 contact at Biomica, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Biomica that raised within 45 days of this round, from Fundz verified event records.

  • CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
  • HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
  • GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.
  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
  • Alpha-9 Theranostics raised $75M (Series B) on December 14, 2022.
  • Entero Therapeutics raised $2.5M (Seed) on November 22, 2022.

Who to call at Biomica, and when

A new round usually means Biomica is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biomica raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biomica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biomica. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biomica

Location

Israel

About

Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biomica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsElran H., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Biomica's next move

See what Strategic adds

Biomica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.